Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CARDIOMIR

Financiado

Cerrado

Development of microRNA Medicines for Cardiac Metabolic Diseases A Targeted Eur...

Development of microRNA Medicines for Cardiac Metabolic Diseases A Targeted European Exchange Programme An urgent need exists for more specific treatment options to target the metabolic changes and the related inflammatory pathways during HF. Targeting microRNAs (miRNAs)-small RNAs implicated in protein regulation- represents a uniq... ver más

31/12/2015

UNIVERSITEIT MAAST...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

UNIVERSITEIT MAASTRICHT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-12-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

UNIVERSITEIT MAASTRICHT

0.00€ | Lider

ULIEGE

N.D. | Participante

CENIX

553.88K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

MICARUS MicroRNA function in cardiac and metabolic disease 2M€ Cerrado

RYC-2009-04599 Análisis metabonómico de la expresión diferencial de miRNA e... 192K€ Cerrado

paTCH Targeting the miR 106b 25 cluster in pathological Cardiac Hy... 94K€ Cerrado

SIRENE Silencing miR 199b to attenuate the progression of heart fai... 150K€ Cerrado

CARDIOEPIGEN Epigenetics and microRNAs in Myocardial Function and Disease 3M€ Cerrado

inHForm Integrative omics of heart failure to inform discovery of no... 1M€ Cerrado

Líder del proyecto

UNIVERSITEIT MAASTRICHT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto An urgent need exists for more specific treatment options to target the metabolic changes and the related inflammatory pathways during HF. Targeting microRNAs (miRNAs)-small RNAs implicated in protein regulation- represents a unique possibility to make novel medicines against HF. In view of the central role of inflammatory pathways in the metabolic syndrome, they expect inflammation miRNAs to be excellent targets to treat HF. Three partners will form a focused and natural industry-academy partnership where essential expertise in clinical and experimental miRNA biology, systems biology and drug development is exchanged. The common goal of the partners is to discover novel miRNAs implicated in the cardiac metabolic disease, to develop medicines targeting these miRNAs, and finally test these innovative miRNA medicines in the metabolic risk induced HF. The project team proposes to support 10 experienced and 1 early stage researchers under the current IAPP Programme. Two of the experience researchers will be recruited for the project. All the researchers will undergo intersectorial movement, either from academia to industry or vice versa. The CardiomiR project aims: • To identify miRNAs that are implicated in adverse cardiac inflammation and metabolic changes resulting in HF, and treat HF using LNA-antimiR therapeutics targeting these miRNAs. • To exchange researchers to be able to productively combine the skills and know-how of antimiR-drug discovery and development, cardiac disease biology as well as systems biology and omics data analysis. • To achieve this, a concerted collaborative effort, exchange and training is proposed here between two academic and one industrial partner University Maastricht (UM, partner 1) , University of Liège (ULG, partner 2) and SANTARIS Pharma (SANTARIS, partner 3) This project consists of 3 RTD work package, a secondment/recruitment workpackage and will concentrate on dissemination (IPR-related) and management.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores